439 related articles for article (PubMed ID: 29024109)
41. Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study.
Kristensen SL; Ahlehoff O; Lindhardsen J; Erichsen R; Lamberts M; Khalid U; Nielsen OH; Torp-Pedersen C; Gislason GH; Hansen PR
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):857-62. PubMed ID: 25316773
[TBL] [Abstract][Full Text] [Related]
42. Proton pump inhibitor use and the antifracture efficacy of alendronate.
Abrahamsen B; Eiken P; Eastell R
Arch Intern Med; 2011 Jun; 171(11):998-1004. PubMed ID: 21321287
[TBL] [Abstract][Full Text] [Related]
43. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.
Özcan C; Deleskog A; Schjerning Olsen AM; Nordahl Christensen H; Lock Hansen M; Hilmar Gislason G
Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):25-35. PubMed ID: 28444162
[TBL] [Abstract][Full Text] [Related]
44. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
[TBL] [Abstract][Full Text] [Related]
45. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
46. Proton-pump Inhibitor Use and Myocardial Infarction: A Nested Case-Control Study in the UK Clinical Practice Research Datalink.
Qian Y; Jick S
Epidemiology; 2020 May; 31(3):423-431. PubMed ID: 31809341
[TBL] [Abstract][Full Text] [Related]
47. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
[TBL] [Abstract][Full Text] [Related]
48. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM;
Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792
[TBL] [Abstract][Full Text] [Related]
49. National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use.
Abraham NS; Castillo DL; Hartman C
Aliment Pharmacol Ther; 2008 Jul; 28(1):97-106. PubMed ID: 18397385
[TBL] [Abstract][Full Text] [Related]
50. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
[TBL] [Abstract][Full Text] [Related]
51. Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in Thailand.
Pannoi T; Promchai C; Apiromruck P; Wongpraphairot S; Dong YH; Yang CC; Pan WC
PeerJ; 2024; 12():e16892. PubMed ID: 38371380
[TBL] [Abstract][Full Text] [Related]
52. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
53. Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
Eltoft A; Arntzen KA; Wilsgaard T; Hansen JB; Mathiesen EB; Johnsen SH
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773576
[TBL] [Abstract][Full Text] [Related]
54. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
55. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
56. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
[TBL] [Abstract][Full Text] [Related]
57. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
Horsdal HT; Mehnert F; Rungby J; Johnsen SP
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
[TBL] [Abstract][Full Text] [Related]
58. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
[TBL] [Abstract][Full Text] [Related]
59. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
60. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
